Università Vita-Salute San Raffaele
Quick facts
Marketed products
- desflurane, isoflurane, sevoflurane
- total intravenous anesthetics · Anesthesiology
Total intravenous anesthetics are a class of drugs that induce and maintain general anesthesia by depressing the central nervous system through enhancement of GABAergic inhibitory neurotransmission.
Phase 3 pipeline
- Phosphocreatine · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Università Vita-Salute San Raffaele portfolio CI brief
- Università Vita-Salute San Raffaele pipeline updates RSS
Frequently asked questions about Università Vita-Salute San Raffaele
What are Università Vita-Salute San Raffaele's marketed drugs?
Top marketed products include desflurane, isoflurane, sevoflurane, total intravenous anesthetics.
What is Università Vita-Salute San Raffaele's pipeline?
Università Vita-Salute San Raffaele has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Phosphocreatine.
Related
- desflurane, isoflurane, sevoflurane
- total intravenous anesthetics · Anesthesiology
- Sector hub: All tracked pharma companies